Human keratinocytes convert 25(OH)D-3 to hormonally active 1 alpha ,25(OH)(
2)D-3 and respond to its antiproliferative/prodifferentiating action in vit
ro and in vivo. Levels and activity of 1 alpha ,25(OH)(2)D-3 are short-live
d, 1 alpha ,25(OH)(2)D-3 induces 24-hydroxylase (CYP24) that rapidly metabo
lizes the hormone, yielding a cascade of side-chain oxidized products and t
his eventually results in the loss of activity. Aiming at stabilizing the l
evels of active hormone, we have searched for potent, selective inhibitors
of CYP24. Selective inhibition was crucial in order to avoid impairment of
1 alpha ,25(OH)(2)D-3 synthesis, catalyzed by 1 alpha -hydroxylase - a rela
ted member of cytochrome P-450 (CYP) superfamily. We describe here the test
ing protocol, using primary human keratinocyte cultures as an appropriate s
ource of CYP24 and 1 alpha -hydroxylase, H-3-25(OH)D-3 (at physiological co
ncentrations) as substrate and sensitive HPLC techniques to analyze the com
plex metabolite profiles. Four hundred potential inhibitors were screened b
y this method; most of them were synthesized in our laboratory. These compo
unds (entitled azoles) were capable of direct binding to the heme iron and
of additional interactions with other parts of the enzyme. In this paper, w
e present VID400 and SDZ 89-443, as first examples of powerful selective CY
P24 inhibitors, As anticipated, these compounds increased the levels of 1 a
lpha -hydroxylated products generated from H-3-25(OH)D-3 and extended their
lifetime. Importantly, blocking of 24-hydroxylation led to a switch in met
abolism, namely to preferential conversion of 1 alpha ,25(OH)(2)D-3 to 1 al
pha ,25(OH)(2)-3epi-D-3. As spin-off from our program, selective inhibitors
of la-hydroxylase were also found (e.g. SDZ 88-357). Using H-3-25(OH)D-3 a
s substrate in the absence of SDZ 88-357, CYP24 showed high preference for
freshly generated 1 alpha -hydroxylated metabolites over abundant 25(OH)D-3
. In the presence of SDZ 88-357, we noticed a great increase in 24-hydroxyl
ation of H-3-25(OH)D-3. Besides their use as valuable tools in elucidating
regulatory mechanisms, inhibitors of VD hydroxylases may give rise to novel
therapeutic strategies, especially in defects of cell growth and different
iation, (C) 2001 Elsevier Science Inc. All rights reserved.